Another therapeutic strategy is Substrate Reduction Therapy (SRT), which aims to decrease the synthesis of glucocerebroside, thereby reducing the substrate load that the deficient enzyme needs to process. This indirect approach does not directly restore catalytic activity but helps manage the disease by lowering the substrate levels.
